NCT00225498View on ClinicalTrials.gov

Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Schizophrenia
Interventions
DRUG

ziprasidone vs risperidone or olanzapine

ziprasidone target dose is 160 mg/day risperidone target dose is 4 mg/day olanzapine target dose is 20 mg/day

Trial Locations (1)

11004

The Zucker Hillside Hospital, Glen Oaks

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
lead

Northwell Health

OTHER